Non-drug hypertension treatment device effectively reduces blood pressure in hypertensive diabetics

Fort Lee, NJ -- October 27, 2005 -- It is estimated that eighty percent of the 10 million Americans suffering from both diabetes and hypertension do not reach goal blood pressure (BP) and are at increased risk for heart, kidney and eye disease. Now, an already available non-drug hypertension treatment device, named RESPeRATE (www.RESPeRATE.com), has demonstrated its ability to significantly lower blood pressure in this specific population.

An interim analysis of the results of the first 38 patients participating in a randomized controlled study of non-insulin-dependent diabetics with uncontrolled blood pressure was presented recently at the European General Practice Research Network meeting. The study, conducted by Dr. Moshe Schein from the HadassahHebrew University Medical Center in Jerusalem, Israel, compared the BP response to 8 weeks of 15-minute daily self-treatment with device-guided slow breathing using the RESPeRATE device with that of a control group that continued their usual care. Medication, diet and physical exercise were unchanged in both groups during the study.

Results show a significant reduction in systolic blood pressure (SBP) of 7.4 mmHg in the treatment group, compared to a rise of 3.1 mmHg in the control group (P<0.005). Thirty-two percent of the RESPeRATE-treated patients reached the target BP of 130/80 mmHg compared with just 5% in the control group (p<0.05). No side effects were observed and compliance with treatment was good. Similar to the previous seven published RESPeRATE studies, which were performed in general hypertensive populations, this study also demonstrated a dose-response relationship. Performing more breathing exercise sessions with RESPeRATE, increased the reduction of systolic blood pressure (p<0.005).

"This is fantastic news for the diabetes community and for InterCure" said Erez Gavish, President & CEO of InterCure, the developer of RESPeRATE. "Diabetes treatment

Contact: Tom Kirwan

Page: 1 2

Related biology news :

1. New approach to pulmonary hypertension shows promise
2. Sleep apnea increases risk of diabetes and hypertension in pregnant women
3. Kent State University and Summa Health System receive NIH grant to study prehypertension
4. Active ingredient in common Chinese herb shown to reduce hypertension
5. Scientific meeting on pulmonary hypertension, December 7-8
6. Lifton honored by two medical societies for work on hypertension
7. Pulmonary hypertension discriminates by race, gender
8. Leveling the field for babies with persistent pulmonary hypertension
9. Low-level exercise delays heart failure, markedly extends lives, even with hypertension
10. Researchers uncover mechanisms leading to portal hypertension
11. First report of cancer drug Gleevec as new target therapy for pulmonary hypertension

Post Your Comments:

(Date:7/2/2020)... CITY, Calif. (PRWEB) , ... July 01, 2020 ... ... biotech company, presented its phase 1a findings of Neihulizumab, a biologic for the ... conference in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the ...
(Date:6/28/2020)... , ... June 25, 2020 ... ... enterprise software solutions for biopharmaceutical R&D, today announced that it has entered ... innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and clinical research ...
(Date:6/23/2020)... England (PRWEB) , ... June 23, 2020 , ... ... Africa supporting sustainable healthcare, and Renovagen Ltd, a UK supplier and manufacturer of ... project to support testing operations in the fight against the COVID-19 pandemic in ...
Breaking Biology News(10 mins):
(Date:8/7/2020)... , ... August 06, 2020 , ... ... vaccine industries, announces it has closed on the purchase of greenfield for a ... Conroe, TX and includes over 21 acres in the initial acquisition, with an ...
(Date:7/31/2020)... ... July 29, 2020 , ... Diversified Technologies, Inc. has ... be configured to drive Klystrons, TWTs, IOTs, and magnetrons. , DTI Radar ... switches in a push-pull configuration; yielding fast fall time for a capacitive load. ...
(Date:7/31/2020)... ... July 30, 2020 , ... Alucio™, ... announced the release of its signature product called Beacon - a content ... other field medical professionals. , Beacon helps MSLs streamline communication and ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra , a ... and food industries, is pleased to announce that Charles Galea has joined its ... , Charles is an accomplished and results-driven sales executive with over 10 years ...
Breaking Biology Technology:
Cached News: